NATCOPHARM.NS
NATCO Pharma Limited$863.90
Jun 12, 2026
Market cap
$154.73B
52w range
—
P / E
—
EPS · FY 2026
$79.21
Volume
—
Revenue · FY 2026
$40.78B
Explain this page
Arphra AIPlain-English read on NATCO Pharma Limited’s valuationCredit early-warning
Structural distance-to-default, its trend and term structure, plus matched rating-agency actions for NATCOPHARM.NS.
No structural credit estimate for NATCOPHARM.NS. The default-risk model (default_risk_estimates) covers a corporate subset — this issuer may be outside it (e.g. financials handled separately, or non-US coverage gaps).